AlphaOS

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

NRXP

NRX Pharmaceuticals, Inc.

$3.16Sep 23, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for NRXP yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 0d ago

NRXP's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on NRXP.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for NRX Pharmaceuticals, Inc. (NRXP) — events, not interpretation.

Event
Last session September 23, 2026 at $3.16.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

NRX Pharmaceuticals, Inc. (NRXP)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for NRX Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:
$136.81M
Revenue:
$1.23M

NRXP earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow NRX Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.